Livmoniplimab
Product Specifications
CAS Number
2412004-88-5
Target
TGF-beta/Smad
Related Pathways
Stem Cells
Purity
0.9871
Bioactivity
Livmoniplimab (ABBV-151; ARGX-115) is a humanised monoclonal antibody targeting LRRC32 (GARP) /TGFβ1, which blocks TGFβ1 release mediated by LRRC32, for the treatment of locally advanced or metastatic solid tumours.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
